Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?

Abstract

Dyschromatopsia occurs frequently in MS patients. It may be associated with a worse disease status and possibly serve as a marker for the detection of subclinical disease progression since it was detected even in the absence of ON. It correlated with thinner peripapillary RNFL thickness and inferior cognitive performance.